Cointime

Praxis Bioresearch

company

About

Praxis Bioresearch is a biopharmaceutical company focused on the discovery and development of therapeutics for chronic neuropsychiatric.

  • 1 - 10

Highlights

Total Funding Amount
$2.90M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$2.90M
Industries
Biotechnology,Pharmaceutical
Founded date
Jan 1, 2014
Number Of Employee
1 - 10
Operating Status
Active

Praxis Biosresearch is a privately-held biopharmaceutical company focused on the discovery and development of novel prodrug stimulants for treatment of a range of chronic neuropsychiatric and neurodegenerative disorders.
Their lead development candidate prodrug PRX-P4-003 is designed to offer the proven therapeutic benefits of currently marketed stimulants while hindering potential for intravenous abuse.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$2.90M
Praxis Bioresearch has raised a total of $2.90M in funding over 2 rounds. Their latest funding was raised on Aug 5, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 5, 2021 Grant $2.90M 1 National Institutes of Health — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Praxis Bioresearch is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant
Cointime
Содержание
компания